rs757350157
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM5
The NM_000249.4(MLH1):c.1150G>A(p.Val384Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,613,434 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V384D) has been classified as Benign.
Frequency
Consequence
NM_000249.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151552Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251430Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135884
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461882Hom.: 0 Cov.: 34 AF XY: 0.00000413 AC XY: 3AN XY: 727246
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151552Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 73940
ClinVar
Submissions by phenotype
Colorectal cancer, hereditary nonpolyposis, type 2 Uncertain:2
This MLH1 missense variant (rs757350157) is rare (<0.1%) in a large population dataset (gnomAD v3.1.2: 1/151552 total alleles; 0.00066%; no homozygotes). It has been reported in ClinVar (Variation ID 405421), but has not been reported in the literature, to our knowledge. Of two bioinformatics tools queried, one predicts that the substitution would be damaging, while the other predicts that it would be tolerated, and the valine residue at this position is evolutionarily conserved across all of the species assessed. We consider the clinical significance of c.1150G>A; p.Val384Ile in MLH1 to be uncertain at this time. -
- -
Lynch syndrome Uncertain:1
- -
not provided Uncertain:1
The MLH1 c.1150G>A (p.Val384Ile) variant has not been reported in the published literature. The frequency of this variant in the general population, 0.000004 (1/251430 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded conflicting predictions that this variant is benign or damaging. Based on the available information, we are unable to determine the clinical significance of this variant. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.V384I variant (also known as c.1150G>A), located in coding exon 12 of the MLH1 gene, results from a G to A substitution at nucleotide position 1150. The valine at codon 384 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Mismatch repair cancer syndrome 1 Uncertain:1
This MLH1 missense variant (rs757350157) is rare (<0.1%) in a large population dataset (gnomAD v3.1.2: 1/151552 total alleles; 0.00066%; no homozygotes). It has been reported in ClinVar (Variation ID 405421), but has not been reported in the literature, to our knowledge. Of two bioinformatics tools queried, one predicts that the substitution would be damaging, while the other predicts that it would be tolerated, and the valine residue at this position is evolutionarily conserved across all of the species assessed. We consider the clinical significance of c.1150G>A; p.Val384Ile in MLH1 to be uncertain at this time. -
Hereditary nonpolyposis colorectal neoplasms Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at